Inventor
ROSSIN RAFFAELLA
NL12 patents
⚠️ This page may combine multiple inventors who share the name “ROSSIN RAFFAELLA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAGWORKS PHARMACEUTICALS B V
6 patentsUS10376594B2Aug 13, 2019
Bio-orthogonal drug activation
TAGWORKS PHARMACEUTICALS B V11 citations91
US10967069B2Apr 6, 2021
Bio-orthogonal drug activation
TAGWORKS PHARMACEUTICALS B V1 citations71
US10927139B2Feb 23, 2021
Chemically cleavable group
TAGWORKS PHARMACEUTICALS B V2 citations71
US11857636B2Jan 2, 2024
Bio-orthogonal drug activation
TAGWORKS PHARMACEUTICALS B V0 citations61
US12186405B2Jan 7, 2025
Cleavable tetrazine used in bio-orthogonal drug activation
TAGWORKS PHARMACEUTICALS B V0 citations58
US11617799B2Apr 4, 2023
Cleavable tetrazine used in bio-orthogonal drug activation
TAGWORKS PHARMACEUTICALS B V1 citations57
ROBILLARD MARC STEFAN
2 patentsUNIV WASHINGTON
2 patentsUS8354093B2Jan 15, 2013
Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer
UNIV WASHINGTON6 citations79
US9095601B2Aug 4, 2015
Cell permeable nanoconjugates of shell-crosslinked knedel (SCK) and peptide nucleic acids (“PNAs”) with uniquely expressed or over-expressed mRNA targeting sequences for early diagnosis and therapy of cancer
UNIV WASHINGTON0 citations47